Innovation Files: Where Tech Meets Public Policy cover image

R&D Costs, Rx Prices, and the Formula for Success in Life Sciences Innovation, With Stephen Ezell

Innovation Files: Where Tech Meets Public Policy

00:00

Is the Rate of Return on a Covin Vaccine Really Important?

Inventure capital, nine out of ten deals fail. That means that the one that succeeds has to make a lot of money. A c b o study found that pharmocidical companies need to make a return of 62 point two % on their successful drugs. And other studies have found that probably three drugs in a given year earn enough financial return to repay company's investments in the rest of their portfolio.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner